SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000950138-05-000144
Filing Date
2005-02-14
Accepted
2005-02-14 13:50:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 ROTH-STARK\2005\FEB 13GAS\FEB 13GA-DOR BIOPHARMA feb13ga-dorbiopharma.txt SC 13G/A 12207
  Complete submission text file 0000950138-05-000144.txt   14254
Mailing Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139
Business Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139 305-534-3383
DOR BIOPHARMA INC (Subject) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-39976 | Film No.: 05606939
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10556 N PORT WASHINGTON RD MEQUON WI 53092
Business Address 4142411810
ROTH MICHAEL (Filed by) CIK: 0001010207 (see all company filings)

Type: SC 13G/A